Pharmacy Daily | UK MHRA OTC push

THE UK Medicine and Healthcare products Regulatory Agency (MHRA) has published its report of the first year’s work of the UK stakeholders’ reclassification of non-prescription medicines platform. The objective of the workshop was to identify how best to involve all stakeholders in the process of reclassifying medicines in the UK from Prescription Only (POM) to Non-prescription and in ensuring access and appropriate use of medicines after reclassification. It was agreed that there needed to be an “overarching Strategic Platform for Reclassification comprising skilled and experienced individuals from stakeholder representative bodies” as well as “ad hoc ‘task and finish’ Reclassification Stakeholder Groups to consider specific reclassification applications”. Involved in the process are representatives from medical and pharmacy professions, from the Department of Health and NHS England and patient representatives.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 18 Feb 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Feb 16